{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:17:47Z","timestamp":1787159867964,"version":"build-2736575974"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Specialized Scientific Research Project of Integrated Traditional Chinese and Western Medicine, Southwest Medical University","award":["2024ZXYZX0"],"award-info":[{"award-number":["2024ZXYZX0"]}]},{"name":"the Specialized Scientific Research Project of Integrated Traditional Chinese and Western Medicine, Southwest Medical University","award":["2025ZXYZX04"],"award-info":[{"award-number":["2025ZXYZX04"]}]},{"name":"the Science and Technology Strategic Cooperation Project between Luzhou Municipal People's Government and Southwest Medical University","award":["2025LZXNYDJC08"],"award-info":[{"award-number":["2025LZXNYDJC08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11864-026-01398-w","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:15:58Z","timestamp":1782846958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs"],"prefix":"10.1007","volume":"27","author":[{"given":"Xingwang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchuan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"1398_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/immadv\/ltac001","volume":"2","author":"T Elliott","year":"2022","unstructured":"Elliott T. Immunotherapy advances: One year on. Immunotherapy Adv. 2022;2:10\u20131093. immadv\/ltac001.","journal-title":"Immunotherapy Adv"},{"key":"1398_CR2","doi-asserted-by":"publisher","unstructured":"Sultan I, Alfaar A, Sultan Y, Salman Z, Qaddoumi I. Trends in childhood cancer: Incidence and survival analysis over 45 years of SEER data. PLoS ONE. 2025;20. https:\/\/doi.org\/10.1371\/journal.pone.0314592.","DOI":"10.1371\/journal.pone.0314592"},{"key":"1398_CR3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10840-024-01761-7","volume":"67","author":"D Akdis","year":"2024","unstructured":"Akdis D, Vogler J, Sieren M-M, Molitor N, Sasse T, Phan H-L, Bartoli L, Grosse N, Saguner AM, Eriksson U, et al. Challenges and pitfalls during CRT implantation in patients with persistent left superior vena cava. J Interventional Cardiac Electrophysiol. 2024;67:1505\u201316. https:\/\/doi.org\/10.1007\/s10840-024-01761-7.","journal-title":"J Interventional Cardiac Electrophysiol"},{"key":"1398_CR4","doi-asserted-by":"publisher","unstructured":"Research CICoND, Safety Evaluation HP, PR China, Key Laboratory of Advanced Drug Preparation Technologies MoEoC PR China, Quality KLoHPfD, Evaluation PC, School of Pharmaceutical Sciences ZU, Zhengzhou 450001 PR China, Research CICoND, Safety Evaluation HP PR China, Key Laboratory of Advanced Drug Preparation Technologies MoEoC PR China, Quality KLoHPfD et al. Sanggenon O induced apoptosis of A549 cells is counterbalanced by protective autophagy. Bioorganic Chemistry 2019;87:688-698. https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.072","DOI":"10.1016\/j.bioorg.2019.03.072"},{"key":"1398_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/circulationaha.116.022514","volume":"134","author":"K Henson","year":"2016","unstructured":"Henson K, Reulen R, Winter D, Bright C, Fidler M, Frobisher C, Guha J, Wong K, Kelly J, Edgar A, et al. Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age The Teenage and Young Adult Cancer Survivor Study. Circulation. 2016;134:1519\u2013. https:\/\/doi.org\/10.1161\/circulationaha.116.022514.","journal-title":"Circulation"},{"key":"1398_CR6","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/jco.2013.49.3205","volume":"31","author":"G Armstrong","year":"2013","unstructured":"Armstrong G, Oeffinger K, Chen Y, Kawashima T, Yasui Y, Leisenring W, Stovall M, Chow E, Sklar C, Mulrooney D, et al. Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer. J Clin Oncol. 2013;31:3673\u2013. https:\/\/doi.org\/10.1200\/jco.2013.49.3205.","journal-title":"J Clin Oncol"},{"key":"1398_CR7","doi-asserted-by":"crossref","unstructured":"Ikonomidis I, Tsilivarakis D, Pavlidis G, Katogiannis K, Kostelli G, Kountouri A, Korakas E, Pliouta L, Michalopoulou E, Thymis J et al. Association of ventricular-arterial interaction with left ventricular remodelling after acute myocardial infarction: a 2-year follow-up study. Eur Heart J 2023;44.","DOI":"10.1093\/eurheartj\/ehad655.2046"},{"key":"1398_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCRESAHA.118.313036","volume":"123","author":"C Rommel","year":"2018","unstructured":"Rommel C, R\u00f6sner S, Lother A, Barg M, Schwaderer M, Gilsbach R, B\u00f6micke T, Schnick T, Mayer S, Doll S, et al. The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia. Circul Res. 2018;123:550\u201363. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313036.","journal-title":"Circul Res"},{"key":"1398_CR9","doi-asserted-by":"publisher","first-page":"e13768","DOI":"10.1111\/acel.13768","volume":"22","author":"M de Boer","year":"2023","unstructured":"de Boer M, te Lintel Hekkert M, Chang J, van Thiel BS, Martens L, Bos MM, de Kleijnen MGJ, Ridwan Y, Octavia Y, van Deel ED, et al. DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice. Aging Cell. 2023;22:e13768. https:\/\/doi.org\/10.1111\/acel.13768.","journal-title":"Aging Cell"},{"key":"1398_CR10","doi-asserted-by":"publisher","unstructured":"Yardeni T, Olali A, Chen H, Wang L, Halton J, Zenab A, Morrow R, Butic A, Murdock D, Waymire K, et al. Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling (122, e2417252121, 2025). Proc Natl Acad Sci USA. 2025;122. https:\/\/doi.org\/10.1073\/pnas.2503874122.","DOI":"10.1073\/pnas.2503874122"},{"key":"1398_CR11","first-page":"103389fcvm20200","volume":"7\u20132020","author":"A Murabito","year":"2020","unstructured":"Murabito A, Hirsch E, Ghigo A. Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer? Front Cardiovasc Med. 2020;7\u20132020:103389fcvm202000035.","journal-title":"Front Cardiovasc Med"},{"key":"1398_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1590\/0004-282x20180111","volume":"76","author":"P Piccardo","year":"2018","unstructured":"Piccardo P, Asher D. Complex proteinopathies and neurodegeneration: insights from the study of transmissible spongiform encephalopathies. Arq Neuropsiquiatr. 2018;76:705\u201312. https:\/\/doi.org\/10.1590\/0004-282x20180111.","journal-title":"Arq Neuropsiquiatr"},{"key":"1398_CR13","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.smim.2023.101849","volume":"70","author":"L Dejas","year":"2023","unstructured":"Dejas L, Santoni K, Meunier E, Lamkanfi M. Regulated cell death in neutrophils: From apoptosis to NETosis and pyroptosis. Semin Immunol. 2023;70:101849. https:\/\/doi.org\/10.1016\/j.smim.2023.101849.","journal-title":"Semin Immunol"},{"key":"1398_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2024.2407147","author":"J Fujii","year":"2024","unstructured":"Fujii J. Redox remodeling of central metabolism as a driving force for cellular protection, proliferation, differentiation, and dysfunction. Free Radic Res. 2024. https:\/\/doi.org\/10.1080\/10715762.2024.2407147.","journal-title":"Free Radic Res"},{"key":"1398_CR15","doi-asserted-by":"publisher","unstructured":"Finley L. Abstract 2730 Metabolic pathway remodeling during cell state transitions. J Biol Chem. 2025;301. https:\/\/doi.org\/10.1016\/j.jbc.2025.109550.","DOI":"10.1016\/j.jbc.2025.109550"},{"key":"1398_CR16","doi-asserted-by":"publisher","unstructured":"Zheng K, Hao Y, Xia C, Cheng S, Yu J, Chen Z, Li Y, Niu Y, Ran S, Wang S, et al. Effects and mechanisms of the myocardial microenvironment on cardiomyocyte proliferation and regeneration. Front Cell Dev Biology. 2024;12. https:\/\/doi.org\/10.3389\/fcell.2024.1429020.","DOI":"10.3389\/fcell.2024.1429020"},{"key":"1398_CR17","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3724\/abbs.2023231","volume":"55","author":"Q Yang","year":"2023","unstructured":"Yang Q, Tian H, Guo Z, Ma Z, Wang G. The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma. Acta Biochim Biophys Sin. 2023;55:1697\u2013706. https:\/\/doi.org\/10.3724\/abbs.2023231.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1398_CR18","doi-asserted-by":"publisher","first-page":"109895","DOI":"10.1016\/j.intimp.2023.109895","volume":"117","author":"X Zhang","year":"2023","unstructured":"Zhang X, Gao Y, Yang B, Ma S, Zuo W, Wei J. The mechanism and treatment of targeted anti-tumour drugs induced cardiotoxicity. Int Immunopharmacol. 2023;117:109895. https:\/\/doi.org\/10.1016\/j.intimp.2023.109895.","journal-title":"Int Immunopharmacol"},{"key":"1398_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s11864-022-01012-9","volume":"23","author":"SN Badiyan","year":"2022","unstructured":"Badiyan SN, Puckett LL, Vlacich G, Schiffer W, Pedersen LN, Mitchell JD, Bergom C. Radiation-Induced Cardiovascular Toxicities. Curr Treat Options Oncol. 2022;23:1388\u2013404. https:\/\/doi.org\/10.1007\/s11864-022-01012-9.","journal-title":"Curr Treat Options Oncol"},{"key":"1398_CR20","doi-asserted-by":"publisher","unstructured":"Tan Y, Li H, Cao G, Xin J, Yan D, Liu Y, Li P, Zhang Y, Shi L, Zhang B, et al. N-terminal domain of CTRP9 promotes cardiac fibroblast activation in myocardial infarction via Rap1\/Mek\/Erk pathway. J Translational Med. 2025;23. https:\/\/doi.org\/10.1186\/s12967-025-06274-z.","DOI":"10.1186\/s12967-025-06274-z"},{"key":"1398_CR21","doi-asserted-by":"publisher","unstructured":"Gao Y, Jiao Y, Gong X, Liu J, Xiao H, Zheng Q. Role of transcription factors in apoptotic cells clearance. Front Cell Dev Biology. 2023;11\u20132023. https:\/\/doi.org\/10.3389\/fcell.2023.1110225.","DOI":"10.3389\/fcell.2023.1110225"},{"key":"1398_CR22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41401-023-01068-9","volume":"44","author":"S-y Sheng","year":"2023","unstructured":"Sheng S-y, Li J-m, Hu X-y, Wang Y. Regulated cell death pathways in cardiomyopathy. Acta Pharmacol Sin. 2023;44:1521\u201335. https:\/\/doi.org\/10.1038\/s41401-023-01068-9.","journal-title":"Acta Pharmacol Sin"},{"key":"1398_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.32604\/or.2024.049757","volume":"33","author":"C He","year":"2025","unstructured":"He C, Zhang T, Xiong W, Wang S, Sun X. Apigenin facilitates apoptosis of acute lymphoblastic leukemia cells via AMP-activated protein kinase-mediated ferroptosis. Oncol Res. 2025;33:421\u20139. https:\/\/doi.org\/10.32604\/or.2024.049757.","journal-title":"Oncol Res"},{"key":"1398_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41420-023-01483-1","volume":"9","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhang N, Ma X, Li M, Feng H. The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity. Cell Death Discovery. 2023;9:184. https:\/\/doi.org\/10.1038\/s41420-023-01483-1.","journal-title":"Cell Death Discovery"},{"key":"1398_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/BCJ20210854","volume":"479","author":"L Lossi","year":"2022","unstructured":"Lossi L. The concept of intrinsic versus extrinsic apoptosis. Biochem J. 2022;479:357\u201384. https:\/\/doi.org\/10.1042\/BCJ20210854.","journal-title":"Biochem J"},{"key":"1398_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Reviews Clin Oncol. 2020;17:395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y.","journal-title":"Nat Reviews Clin Oncol"},{"key":"1398_CR27","doi-asserted-by":"publisher","first-page":"eaaz7548","DOI":"10.1126\/science.aaz7548","volume":"368","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, Wang Y, Li D, Liu W, Zhang Y, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368:eaaz7548. https:\/\/doi.org\/10.1126\/science.aaz7548.","journal-title":"Science"},{"key":"1398_CR28","doi-asserted-by":"publisher","unstructured":"Hughes S, Lin M, Weir A, Huang B, Xiong L, Chua N, Pang J, Santavanond J, Tixeira R, Doerflinger M, et al. Caspase-8-driven apoptotic and pyroptotic crosstalk causes cell death and IL-1\u03b2 release in X-linked inhibitor of apoptosis (XIAP) deficiency. EMBO J. 2023;42. https:\/\/doi.org\/10.15252\/embj.2021110468.","DOI":"10.15252\/embj.2021110468"},{"key":"1398_CR29","doi-asserted-by":"publisher","unstructured":"Jiang M, Qi L, Li L, Li Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discovery. 2020;6. https:\/\/doi.org\/10.1038\/s41420-020-00349-0.","DOI":"10.1038\/s41420-020-00349-0"},{"key":"1398_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1139\/bcb-2019-0450","volume":"100","author":"Q Chen","year":"2022","unstructured":"Chen Q, Chen L, Jian J, Li J, Zhang XRETRACTED. The mechanism behind BAF60c in myocardial metabolism in rats with heart failure is through the PGC1\u03b1-PPAR\u03b1-mTOR signaling pathwayRetracted article. See vol. 103, 2025). Retracted: Biochem Cell Biology. 2022;100:93\u2013103. . https:\/\/doi.org\/10.1139\/bcb-2019-0450","journal-title":"Retracted: Biochem Cell Biology"},{"key":"1398_CR31","doi-asserted-by":"publisher","unstructured":"Zhang G, Yuan C, Su X, Zhang J, Gokulnath P, Vulugundam G, Li G, Yang X, An N, Liu C, et al. Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments. Front Cardiovasc Med. 2022;9. https:\/\/doi.org\/10.3389\/fcvm.2022.896792.","DOI":"10.3389\/fcvm.2022.896792"},{"key":"1398_CR32","doi-asserted-by":"publisher","first-page":"113279","DOI":"10.1016\/j.biopha.2022.113279","volume":"153","author":"D Li","year":"2022","unstructured":"Li D, Pi W, Sun Z, Liu X, Jiang J. Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother. 2022;153:113279. https:\/\/doi.org\/10.1016\/j.biopha.2022.113279.","journal-title":"Biomed Pharmacother"},{"key":"1398_CR33","doi-asserted-by":"publisher","unstructured":"Kuno S, Fujita H, Tanaka Yk, Ogra Y, Iwai K. Iron-induced NCOA4 condensation regulates ferritin fate and iron homeostasis. EMBO Rep. 2022;23. https:\/\/doi.org\/10.15252\/embr.202154278.","DOI":"10.15252\/embr.202154278"},{"key":"1398_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/EBC20190082","volume":"64","author":"WW Christie","year":"2020","unstructured":"Christie WW, Harwood JL. Oxidation of polyunsaturated fatty acids to produce lipid mediators. Essays Biochem. 2020;64:401\u201321. https:\/\/doi.org\/10.1042\/EBC20190082.","journal-title":"Essays Biochem"},{"key":"1398_CR35","doi-asserted-by":"publisher","unstructured":"Wang W, Zhong X, Fang Z, Li J, Li H, Liu X, Yuan X, Huang W, Huang Z. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2\/Keap1 pathway. Chemico-Biol Interact. 2023;377. https:\/\/doi.org\/10.1016\/j.cbi.2023.110469.","DOI":"10.1016\/j.cbi.2023.110469"},{"key":"1398_CR36","doi-asserted-by":"publisher","unstructured":"Wang L, Qiao Y, Yu J, Wang Q, Wu X, Cao Q, Zhang Z, Feng Z, He H. Endurance exercise preconditioning alleviates ferroptosis induced by doxorubicin-induced cardiotoxicity through mitochondrial superoxide-dependent AMPK\u03b12 activation. Redox Biol. 2024;70. https:\/\/doi.org\/10.1016\/j.redox.2024.103079.","DOI":"10.1016\/j.redox.2024.103079"},{"key":"1398_CR37","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.7150\/thno.100080","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Zhang G, Hu J, Tian Y, Fu X. Ferroptosis at the nexus of metabolism and metabolic diseases. Theranostics. 2024;14:5826\u201352. https:\/\/doi.org\/10.7150\/thno.100080.","journal-title":"Theranostics"},{"key":"1398_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tem.2025.06.007","volume":"37","author":"Y Li","year":"2026","unstructured":"Li Y, Wang X. A metabolic perspective on cuproptosis. Trends Endocrinol Metabolism. 2026;37:277\u201387. https:\/\/doi.org\/10.1016\/j.tem.2025.06.007.","journal-title":"Trends Endocrinol Metabolism"},{"key":"1398_CR39","doi-asserted-by":"publisher","unstructured":"Chen H, Li D, Zhang H, Zhang M, Lin Y, He H, Liu A, Shen S, Wang Y, Han Z. Mechanisms of copper metabolism and cuproptosis: implications for liver diseases. Front Immunol. 2025;16\u20132025. https:\/\/doi.org\/10.3389\/fimmu.2025.1633711.","DOI":"10.3389\/fimmu.2025.1633711"},{"key":"1398_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.semcancer.2024.09.003","volume":"106\u2013107","author":"F Yang","year":"2024","unstructured":"Yang F, Zhang G, An N, Dai Q, Cho W, Shang H, Xing Y. Interplay of ferroptosis, cuproptosis, and PANoptosis in cancer treatment-induced cardiotoxicity: Mechanisms and therapeutic implications. Semin Cancer Biol. 2024;106\u2013107:106\u201322. https:\/\/doi.org\/10.1016\/j.semcancer.2024.09.003.","journal-title":"Semin Cancer Biol"},{"key":"1398_CR41","doi-asserted-by":"publisher","unstructured":"Lv Y, Li Q, Yin L, He S, Qin C, Lu Z, Chen H. Cuproptosis in ccRCC: key player in therapeutic and prognostic targets. Front Oncol. 2023;13\u20132023. https:\/\/doi.org\/10.3389\/fonc.2023.1271864.","DOI":"10.3389\/fonc.2023.1271864"},{"key":"1398_CR42","doi-asserted-by":"publisher","unstructured":"Zhou J, Wang C, Zhi Y, Li J. The potential role of cuproptosis-related genes for therapy and immunoregulation in pan-cancer. PLoS ONE. 2025;20. https:\/\/doi.org\/10.1371\/journal.pone.0324389.","DOI":"10.1371\/journal.pone.0324389"},{"key":"1398_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14348\/molcells.2023.0060","volume":"46","author":"D Shao","year":"2023","unstructured":"Shao D, Shi L, Ji H, Disulfidptosis. Disulfide Stress Mediates a Novel Cell Death Pathway via Actin Cytoskeletal Vulnerability. Mol Cells. 2023;46:414\u20136. https:\/\/doi.org\/10.14348\/molcells.2023.0060.","journal-title":"Mol Cells"},{"key":"1398_CR44","doi-asserted-by":"publisher","first-page":"9450","DOI":"10.3390\/cimb45120593","volume":"45","author":"L Ni","year":"2023","unstructured":"Ni L, Yu Q, You R, Chen C, Peng B. Development of the RF-GSEA Method for Identifying Disulfidptosis-Related Genes and Application in Hepatocellular Carcinoma. Curr Issues Mol Biol. 2023;45:9450\u201370. https:\/\/doi.org\/10.3390\/cimb45120593.","journal-title":"Curr Issues Mol Biol"},{"key":"1398_CR45","doi-asserted-by":"publisher","unstructured":"She F, Liu K, Anderson B, Pisithkul T, Li Y, Fung D, Mccue T, Mulhern W, Amador-Noguez D, Wang J. Pyruvate kinase directly generates GTP in glycolysis, supporting growth and contributing to guanosine toxicity. Mbio. 2025;16. https:\/\/doi.org\/10.1128\/mbio.03798-24.","DOI":"10.1128\/mbio.03798-24"},{"key":"1398_CR46","doi-asserted-by":"publisher","unstructured":"Rydz L, Wr\u00f3bel M, Janik K, Jurkowska H. Hypoxia-induced changes in L-cysteine metabolism and antioxidative processes in melanoma cells. Biomolecules. 2023;13. https:\/\/doi.org\/10.3390\/biom13101491.","DOI":"10.3390\/biom13101491"},{"key":"1398_CR47","doi-asserted-by":"publisher","unstructured":"Zhu W, Liu Y, Yu Z, Wang H. SLC7A11-mediated cell death mechanism in cancer: a comparative study of disulfidptosis and ferroptosis. Front Cell Dev Biology. 2025;13. https:\/\/doi.org\/10.3389\/fcell.2025.1559423.","DOI":"10.3389\/fcell.2025.1559423"},{"key":"1398_CR48","doi-asserted-by":"publisher","first-page":"e13752","DOI":"10.1111\/cpr.13752","volume":"58","author":"Y Li","year":"2025","unstructured":"Li Y, Zhang H, Yang F, Zhu D, Chen S, Wang Z, Wei Z, Yang Z, Jia J, Zhang Y, et al. Mechanisms and therapeutic potential of disulphidptosis in cancer. Cell Prolif. 2025;58:e13752. https:\/\/doi.org\/10.1111\/cpr.13752.","journal-title":"Cell Prolif"},{"key":"1398_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s12276-024-01389-7","volume":"57","author":"H Ji","year":"2025","unstructured":"Ji H, Ma W, Liu X, Chen H, Liu Y, Ren Z, Yin D, Cai A, Zhang Z, Wang X, et al. IFN-\u03b3 reprograms cardiac microvascular endothelial cells to mediate doxorubicin transport and influences the sensitivity of mice to doxorubicin-induced cardiotoxicity. Experimental Mol Med. 2025;57:249\u201363. https:\/\/doi.org\/10.1038\/s12276-024-01389-7.","journal-title":"Experimental Mol Med"},{"key":"1398_CR50","doi-asserted-by":"publisher","unstructured":"Qiu Y, Bai L, Zhao H, Mei X. Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK\/H2AX\/Mcl-1 axis. BMC Cancer. 2024;24. https:\/\/doi.org\/10.1186\/s12885-024-12286-7.","DOI":"10.1186\/s12885-024-12286-7"},{"key":"1398_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10495-020-01628-y","volume":"25","author":"AJ Ghio","year":"2020","unstructured":"Ghio AJ. Letter to the editor: iron, apoptosis, and ferroptosis. Apoptosis. 2020;25:605\u20136. https:\/\/doi.org\/10.1007\/s10495-020-01628-y.","journal-title":"Apoptosis"},{"key":"1398_CR52","doi-asserted-by":"publisher","unstructured":"Oh S-J, Ikeda M, Ide T, Hur KY, Lee M-S. Mitochondrial event as an ultimate step in ferroptosis. Cell Death Discovery. 2022;8. https:\/\/doi.org\/10.1038\/s41420-022-01199-8.","DOI":"10.1038\/s41420-022-01199-8"},{"key":"1398_CR53","doi-asserted-by":"publisher","unstructured":"Paulus MG, Renner K, Nickel AG, Brochhausen C, Limm K, Z\u00fcgner E, Baier MJ, Pabel S, Wallner S, Birner C, et al. Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions. Basic Res Cardiol. 2022;117. https:\/\/doi.org\/10.1007\/s00395-022-00949-0.","DOI":"10.1007\/s00395-022-00949-0"},{"key":"1398_CR54","doi-asserted-by":"publisher","unstructured":"Schachter J, Guijarro A, Angosto-Bazarra D, Pinilla M, Hurtado-Navarro L, Meunier E, P\u00e9rez-Oliva A, Schwarzbaum P, Pelegrin P. Gasdermin D mediates a fast transient release of ATP after NLRP3 inflammasome activation before ninjurin 1-induced lytic cell death. Cell Rep. 2025;44. https:\/\/doi.org\/10.1016\/j.celrep.2025.115233.","DOI":"10.1016\/j.celrep.2025.115233"},{"key":"1398_CR55","doi-asserted-by":"publisher","unstructured":"Jo W, Won T, Daoud A, \u010cih\u00e1kov\u00e1 D. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1340373.","DOI":"10.3389\/fimmu.2024.1340373"},{"key":"1398_CR56","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1182\/blood-2024-205797","volume":"144","author":"C Koch","year":"2024","unstructured":"Koch C, Fullin J, Topcu E, Klemm N, Zielinska K, Hebeisen M, Tchinda J, Manz M, Boettcher S. Modelling the Evolution of Clonal Hematopoiesis to Myeloid Malignancies Under the Selective Pressure of Anti-Cancer Therapy. Blood. 2024;144:5651\u20132. https:\/\/doi.org\/10.1182\/blood-2024-205797.","journal-title":"Blood"},{"key":"1398_CR57","doi-asserted-by":"publisher","unstructured":"Sun S, Jiao X, Chen Z, Cao Q, Zhu J, Shen Q, Liu Y, Zhang Z, Xu F, Shi Y, et al. Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-50996-5.","DOI":"10.1038\/s41467-024-50996-5"},{"key":"1398_CR58","doi-asserted-by":"publisher","unstructured":"Kr\u00fcger M, Remove. Refine, Reduce: Cell Death in Biological Systems. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24087028.","DOI":"10.3390\/ijms24087028"},{"key":"1398_CR59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.immuni.2024.12.007","volume":"58","author":"S Yang","year":"2025","unstructured":"Yang S, Huang G, Ting JPY. Mitochondria and NLRP3: To die or inflame. Immunity. 2025;58:5\u20137. https:\/\/doi.org\/10.1016\/j.immuni.2024.12.007.","journal-title":"Immunity"},{"key":"1398_CR60","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41418-019-0382-x","volume":"27","author":"A Yalonetskaya","year":"2020","unstructured":"Yalonetskaya A, Mondragon AA, Hintze ZJ, Holmes S, McCall K. Nuclear degradation dynamics in a nonapoptotic programmed cell death. Cell Death Differ. 2020;27:711\u201324. https:\/\/doi.org\/10.1038\/s41418-019-0382-x.","journal-title":"Cell Death Differ"},{"key":"1398_CR61","doi-asserted-by":"publisher","unstructured":"Peng R, Wang CK, Wang-Kan X, Idorn M, Kj\u00e6r M, Zhou FY, Fiil BK, Timmermann F, Orozco SL, McCarthy J, et al. Human ZBP1 induces cell death\u2010independent inflammatory signaling via RIPK3 and RIPK1. EMBO Rep. 2022;23. https:\/\/doi.org\/10.15252\/embr.202255839.","DOI":"10.15252\/embr.202255839"},{"key":"1398_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-019-1752-8","volume":"575","author":"K Newton","year":"2019","unstructured":"Newton K, Wickliffe KE, Maltzman A, Dugger DL, Reja R, Zhang Y, Roose-Girma M, Modrusan Z, Sagolla MS, Webster JD, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575:679\u201382. https:\/\/doi.org\/10.1038\/s41586-019-1752-8.","journal-title":"Nature"},{"key":"1398_CR63","doi-asserted-by":"publisher","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, Liu Y, Zhao X, Qian L, Liu P, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discovery. 2021;7. https:\/\/doi.org\/10.1038\/s41420-021-00579-w.","DOI":"10.1038\/s41420-021-00579-w"},{"key":"1398_CR64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00204-023-03665-3","volume":"98","author":"K Hou","year":"2024","unstructured":"Hou K, Liu L, Fang Z-H, Zong W-X, Sun D, Guo Z, Cao L. The role of ferroptosis in cardio-oncology. Arch Toxicol. 2024;98:709\u201334. https:\/\/doi.org\/10.1007\/s00204-023-03665-3.","journal-title":"Arch Toxicol"},{"key":"1398_CR65","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.freeradbiomed.2025.05.243","volume":"233","author":"K Yamada","year":"2025","unstructured":"Yamada K. -i. Lysosomal lipid peroxidation induces ferroptosis via lysosomal membrane permeabilization. Free Radic Biol Med. 2025;233:S69. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.05.243.","journal-title":"Free Radic Biol Med"},{"key":"1398_CR66","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/febs.16382","volume":"290","author":"H Nishizawa","year":"2023","unstructured":"Nishizawa H, Yamanaka M, Igarashi K. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal. FEBS J. 2023;290:1688\u2013704. https:\/\/doi.org\/10.1111\/febs.16382.","journal-title":"FEBS J"},{"key":"1398_CR67","doi-asserted-by":"publisher","unstructured":"Nakamura T, Ogawa M, Kojima K, Takayanagi S, Ishihara S, Hattori K, Naguro I, Ichijo H. The mitochondrial Ca2\u2009+\u2009uptake regulator, MICU1, is involved in cold stress-induced ferroptosis. EMBO Rep. 2021;22. https:\/\/doi.org\/10.15252\/embr.202051532.","DOI":"10.15252\/embr.202051532"},{"key":"1398_CR68","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41417-024-00765-9","volume":"31","author":"J Gao","year":"2024","unstructured":"Gao J, Xiong A, Liu J, Li X, Wang J, Zhang L, Liu Y, Xiong Y, Li G, He X. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer Gene Ther. 2024;31:970\u201383. https:\/\/doi.org\/10.1038\/s41417-024-00765-9.","journal-title":"Cancer Gene Ther"},{"key":"1398_CR69","doi-asserted-by":"publisher","unstructured":"Kornfeld OS, Qvit N, Haileselassie B, Shamloo M, Bernardi P, Mochly-Rosen D. Interaction of mitochondrial fission factor with dynamin related protein 1 governs physiological mitochondrial function in vivo. Sci Rep. 2018;8. https:\/\/doi.org\/10.1038\/s41598-018-32228-1.","DOI":"10.1038\/s41598-018-32228-1"},{"key":"1398_CR70","doi-asserted-by":"publisher","first-page":"e202002179","DOI":"10.1083\/jcb.202002179","volume":"219","author":"JX Tan","year":"2020","unstructured":"Tan JX, Finkel T. Mitochondria as intracellular signaling platforms in health and disease. J Cell Biol. 2020;219:e202002179. https:\/\/doi.org\/10.1083\/jcb.202002179.","journal-title":"J Cell Biol"},{"key":"1398_CR71","doi-asserted-by":"publisher","unstructured":"Borankova K, Solny M, Krchniakova M, Skoda J. Depleting chemoresponsive mitochondrial fission mediator DRP1 does not mitigate sarcoma resistance. Life Sci Alliance. 2025;8. https:\/\/doi.org\/10.26508\/lsa.202402870.","DOI":"10.26508\/lsa.202402870"},{"key":"1398_CR72","doi-asserted-by":"publisher","unstructured":"T\u00e1bara LC, Prudent J. The last wall of defense to prevent extreme and deleterious mitochondrial fusion. EMBO J. 2020;39. https:\/\/doi.org\/10.15252\/embj.2020107326.","DOI":"10.15252\/embj.2020107326"},{"key":"1398_CR73","doi-asserted-by":"publisher","unstructured":"Lin W, Wang X, Diao M, Wang Y, Zhao R, Chen J, Liao Y, Long Q, Meng Y. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer. Cancer Cell Int. 2024;24. https:\/\/doi.org\/10.1186\/s12935-024-03418-x.","DOI":"10.1186\/s12935-024-03418-x"},{"key":"1398_CR74","doi-asserted-by":"publisher","first-page":"eaao6129","DOI":"10.1126\/scitranslmed.aao6129","volume":"9","author":"K Sarosiek","year":"2017","unstructured":"Sarosiek K. Blocking cell death to enhance cell death. Sci Transl Med. 2017;9:eaao6129. https:\/\/doi.org\/10.1126\/scitranslmed.aao6129.","journal-title":"Sci Transl Med"},{"key":"1398_CR75","doi-asserted-by":"publisher","unstructured":"Basak B, Holzbaur E. Mitochondrial damage triggers the concerted degradation of negative regulators of neuronal autophagy. Nat Commun. 2025;16. https:\/\/doi.org\/10.1038\/s41467-025-62379-5.","DOI":"10.1038\/s41467-025-62379-5"},{"key":"1398_CR76","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.devcel.2024.09.007","volume":"59","author":"B Conradt","year":"2024","unstructured":"Conradt B, Miao EA, Yuan J, Kanneganti T-D, Stockwell BR, Tsvetkov P, Overholtzer M, Gan B. The story behind the emergence of different forms of cell death. Dev Cell. 2024;59:2519\u201322. https:\/\/doi.org\/10.1016\/j.devcel.2024.09.007.","journal-title":"Dev Cell"},{"key":"1398_CR77","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","volume":"66","author":"B Zhou","year":"2020","unstructured":"Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89\u2013100. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.002.","journal-title":"Semin Cancer Biol"},{"key":"1398_CR78","doi-asserted-by":"publisher","unstructured":"Franzese O, Ancona P, Bianchi N, Aguiari G. Apoptosis, a metabolic head-to-head between tumor and T cells: Implications for Immunotherapy. Cells. 2024;13. https:\/\/doi.org\/10.3390\/cells13110924.","DOI":"10.3390\/cells13110924"},{"key":"1398_CR79","doi-asserted-by":"publisher","unstructured":"Olatunde A, Nigam M, Singh R, Panwar A, Lasisi A, Alhumaydhi F, Kumar V, Mishra A, Sharifi-Rad J. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int. 2021;21. https:\/\/doi.org\/10.1186\/s12935-021-02202-5.","DOI":"10.1186\/s12935-021-02202-5"},{"key":"1398_CR80","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","volume":"120","author":"Q Sun","year":"2024","unstructured":"Sun Q, Karwi QG, Wong N, Lopaschuk GD. Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond. Cardiovascular Res. 2024;120:1996\u20132016. https:\/\/doi.org\/10.1093\/cvr\/cvae231.","journal-title":"Cardiovascular Res"},{"key":"1398_CR81","doi-asserted-by":"publisher","unstructured":"Zhou W, VanDuyne P, Zhang C, Liu Y, Riessen R, Barragan M, Rowitz BM, Teran-Garcia M, Boppart SA, Anakk S. Pathological bile acid concentrations in chronic cholestasis cause adipose mitochondrial defects. JHEP Rep. 2023;5. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100714.","DOI":"10.1016\/j.jhepr.2023.100714"},{"key":"1398_CR82","doi-asserted-by":"publisher","unstructured":"Zhu Y-p, Zheng Z, Xiang Y, Zhang Y. Glucose starvation-induced rapid death of Nrf1\u03b1-Deficient, but not Nrf2-deficient, hepatoma cells results from its fatal defects in the redox metabolism reprogramming. Oxidative Med Cell Longev. 2020;2020(4959821). https:\/\/doi.org\/10.1155\/2020\/4959821.","DOI":"10.1155\/2020\/4959821"},{"key":"1398_CR83","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/s41388-025-03472-3","volume":"44","author":"B Cong","year":"2025","unstructured":"Cong B, Thakur T, Uribe AH, Stamou E, Gopinath S, Sansom O, Maddocks O, Cagan R. Colon cancer cells evade drug action by enhancing drug metabolism. Oncogene. 2025;44:3284\u201396. https:\/\/doi.org\/10.1038\/s41388-025-03472-3.","journal-title":"Oncogene"},{"key":"1398_CR84","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.freeradbiomed.2024.04.125","volume":"218","author":"J Arean","year":"2024","unstructured":"Arean J, Aran A, Pappalettera B, Vico T, Evelson P, Vanasco V, Alvarez S, ENDOTOXEMIA IN H9C2 CARDIOMYOCYTES. INSIGHTS INTO MITOCHONDRIAL DYNAMICS, BIOENERGETICS AND ROS PRODUCTION. Free Radic Biol Med. 2024;218:34\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.125.","journal-title":"Free Radic Biol Med"},{"key":"1398_CR85","doi-asserted-by":"publisher","first-page":"eads5466","DOI":"10.1126\/sciadv.ads5466","volume":"10","author":"CR Reczek","year":"2024","unstructured":"Reczek CR, Chakrabarty RP, D\u2019Alessandro KB, Sebo ZL, Grant RA, Gao P, Budinger GR, Chandel NS. Metformin targets mitochondrial complex I to lower blood glucose levels. Sci Adv. 2024;10:eads5466. https:\/\/doi.org\/10.1126\/sciadv.ads5466.","journal-title":"Sci Adv"},{"key":"1398_CR86","doi-asserted-by":"publisher","unstructured":"Damy T, Kirsch M, Khouzami L, Caramelle P, Le Corvoisier P, Roudot-Thoraval F, Dubois-Rand\u00e9 J, Hittinger L, Pavoine C, Pecker F. Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities. PLoS ONE. 2009;4. https:\/\/doi.org\/10.1371\/journal.pone.0004871.","DOI":"10.1371\/journal.pone.0004871"},{"key":"1398_CR87","doi-asserted-by":"publisher","unstructured":"Kuang F, Liu J, Tang D, Kang R. Oxidative damage and antioxidant defense in ferroptosis. Front Cell Dev Biology. 2020;8\u20132020. https:\/\/doi.org\/10.3389\/fcell.2020.586578.","DOI":"10.3389\/fcell.2020.586578"},{"key":"1398_CR88","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/circulationaha.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen R, Moller N, Gormsen L, Tolbod L, Hansson N, Sorensen J, Harms H, Froki\u00e6r J, Eiskjaer H, Jespersen N, et al. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation. 2019;139:2129\u201341. https:\/\/doi.org\/10.1161\/circulationaha.118.036459.","journal-title":"Circulation"},{"key":"1398_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","volume":"20","author":"SM Ng","year":"2023","unstructured":"Ng SM, Neubauer S, Rider OJ. Myocardial Metabolism in Heart Failure. Curr Heart Fail Rep. 2023;20:63\u201375. https:\/\/doi.org\/10.1007\/s11897-023-00589-y.","journal-title":"Curr Heart Fail Rep"},{"key":"1398_CR90","doi-asserted-by":"crossref","unstructured":"Russo M, Guerra G, Priolo R, Riganti C, Reano S, Filigheddu N, Hirsch E, Ghigo A. Cardiometabolic rewiring in the context of doxorubicin-induced cardiotoxicity: fuel preference changes from fatty acids to glucose oxidation. European Heart Journal 2023, 44.","DOI":"10.1093\/eurheartj\/ehad655.3086"},{"key":"1398_CR91","doi-asserted-by":"publisher","first-page":"A10825","DOI":"10.1161\/circ.146.suppl_1.10825","volume":"146","author":"M Yang","year":"2022","unstructured":"Yang M, Xiong S, Tan J, Li Y, Shen C, Wu T, Fu X, Feng Z, Ji Y, Zheng H, et al. Abstract 10825: Tumor-Bearing Induces Cardiomyopathy by Disrupting Cardiometabolic Reprogramming. Circulation. 2022;146:A10825\u201310825. https:\/\/doi.org\/10.1161\/circ.146.suppl_1.10825.","journal-title":"Circulation"},{"key":"1398_CR92","doi-asserted-by":"publisher","unstructured":"Liu X, Xie P, Hao N, Zhang M, Liu Y, Liu P, Semenza G, He J, Zhang H. HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt\/\u03b2-catenin pathway activation (118, e2109144118, 2021). Proc Natl Acad Sci USA. 2022;119. https:\/\/doi.org\/10.1073\/pnas.2121952119.","DOI":"10.1073\/pnas.2121952119"},{"key":"1398_CR93","doi-asserted-by":"publisher","unstructured":"Njock M, O\u2019Grady T, Nivelles O, Lion M, Jacques S, Cambier M, Herkenne S, Muller F, Christian A, Remacle C, et al. Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming. J Extracell Vesicles. 2022;11. https:\/\/doi.org\/10.1002\/jev2.12228.","DOI":"10.1002\/jev2.12228"},{"key":"1398_CR94","doi-asserted-by":"publisher","unstructured":"Reggiani F, Sauta E, Torricelli F, Zanetti E, Tagliavini E, Santandrea G, Gobbi G, Damia G, Bellazzi R, Ambrosetti D, et al. An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma. Mol Cancer. 2021;20. https:\/\/doi.org\/10.1186\/s12943-021-01357-z.","DOI":"10.1186\/s12943-021-01357-z"},{"key":"1398_CR95","doi-asserted-by":"publisher","unstructured":"Seo W, Yoo S, Zhong Y, Lee S, Woo S, Choi H, Won M, Roh T, Jeon S, Kim K, et al. Targeting ERR\u03b1 promotes cytotoxic effects against acute myeloid leukemia through suppressing mitochondrial oxidative phosphorylation. J Hematol Oncol. 2022;15. https:\/\/doi.org\/10.1186\/s13045-022-01372-7.","DOI":"10.1186\/s13045-022-01372-7"},{"key":"1398_CR96","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1002\/1878-0261.13261","volume":"16","author":"S Drapela","year":"2022","unstructured":"Drapela S, Ilter D, Gomes AP. Metabolic reprogramming: a bridge between aging and tumorigenesis. Mol Oncol. 2022;16:3295\u2013318. https:\/\/doi.org\/10.1002\/1878-0261.13261.","journal-title":"Mol Oncol"},{"key":"1398_CR97","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","volume":"30","author":"V Pucino","year":"2019","unstructured":"Pucino V, Certo M, Bulusu V, Cucchi D, Goldmann K, Pontarini E, Haas R, Smith J, Headland S, Blighe K, et al. Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4\u2009+\u2009T Cell Metabolic Rewiring. Cell Metabol. 2019;30:1055\u2013. https:\/\/doi.org\/10.1016\/j.cmet.2019.10.004.","journal-title":"Cell Metabol"},{"key":"1398_CR98","doi-asserted-by":"publisher","first-page":"193","DOI":"10.14348\/molcells.2021.0260","volume":"45","author":"J Lee","year":"2022","unstructured":"Lee J, Lee S, Min S, Kang SW. RIP3-Dependent Accumulation of Mitochondrial Superoxide Anions in TNF-\u03b1-Induced Necroptosis. Mol Cells. 2022;45:193\u2013201. https:\/\/doi.org\/10.14348\/molcells.2021.0260.","journal-title":"Mol Cells"},{"key":"1398_CR99","doi-asserted-by":"publisher","unstructured":"Choi E, Kim M, Park S. Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25147952.","DOI":"10.3390\/ijms25147952"},{"key":"1398_CR100","doi-asserted-by":"publisher","unstructured":"Linders AN, Dias IB, L\u00f3pez Fern\u00e1ndez T, Tocchetti CG, Bomer N, Van der Meer P. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. npj Aging. 2024;10. https:\/\/doi.org\/10.1038\/s41514-024-00135-7.","DOI":"10.1038\/s41514-024-00135-7"},{"key":"1398_CR101","doi-asserted-by":"publisher","unstructured":"Rao X, Zhou D, Deng H, Chen Y, Wang J, Zhou X, Jie X, Xu Y, Wu Z, Wang G, et al. Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury. Respir Res. 2023;24. https:\/\/doi.org\/10.1186\/s12931-023-02331-7.","DOI":"10.1186\/s12931-023-02331-7"},{"key":"1398_CR102","doi-asserted-by":"publisher","unstructured":"Zhang J, Ma T, Xian L, Guo Z. Dynamic properties of enhancer and promoter during DNA damage in hepatocellular carcinoma. iScience. 2025;28. https:\/\/doi.org\/10.1016\/j.isci.2025.112565.","DOI":"10.1016\/j.isci.2025.112565"},{"key":"1398_CR103","doi-asserted-by":"publisher","unstructured":"Parikh M, Pierce G. A brief review on the biology and effects of cellular and circulating microRNAs on cardiac remodeling after infarction. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22094995.","DOI":"10.3390\/ijms22094995"},{"key":"1398_CR104","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41580-024-00816-x","volume":"26","author":"K Baumann","year":"2025","unstructured":"Baumann K. Fat cells have long-lasting (epigenetic) memory. Nat Rev Mol Cell Biol. 2025;26:7\u20137. https:\/\/doi.org\/10.1038\/s41580-024-00816-x.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1398_CR105","doi-asserted-by":"publisher","unstructured":"Robinson E, Ameri P, Delrue L, Vanderheyden M, Bartunek J, Altieri P, Heymans S, Heggermont W. Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity. Front Cardiovasc Med. 2023;10. https:\/\/doi.org\/10.3389\/fcvm.2023.884174.","DOI":"10.3389\/fcvm.2023.884174"},{"key":"1398_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.09.012","volume":"113","author":"T Yoshii","year":"2017","unstructured":"Yoshii T, Hosokawa H, Matsuo N. Pharmacogenetic reactivation of the original engram evokes an extinguished fear memory. Neuropharmacology. 2017;113:1\u20139. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.012.","journal-title":"Neuropharmacology"},{"key":"1398_CR107","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1089\/ten.teb.2022.0050","volume":"28","author":"A Chang","year":"2022","unstructured":"Chang A, Tam J, Agrawal D, Liu H, Varadarajan P, Pai R, Thankam F. Synthetic Fibroblasts: Terra Incognita in Cardiac Regeneration. Tissue Eng Part B-Reviews. 2022;28:1235\u201341. https:\/\/doi.org\/10.1089\/ten.teb.2022.0050.","journal-title":"Tissue Eng Part B-Reviews"},{"key":"1398_CR108","doi-asserted-by":"publisher","first-page":"e13523","DOI":"10.1111\/apha.13523","volume":"229","author":"D Ivy","year":"2020","unstructured":"Ivy D. The failing right ventricle: Where do we go from here. Acta Physiol. 2020;229:e13523. https:\/\/doi.org\/10.1111\/apha.13523.","journal-title":"Acta Physiol"},{"key":"1398_CR109","doi-asserted-by":"publisher","unstructured":"Norl\u00e9n L. Molecular Organization of the Skin Barrier. Acta Dermato-Venereologica. 2023;103. https:\/\/doi.org\/10.2340\/actadv.v103.13356.","DOI":"10.2340\/actadv.v103.13356"},{"key":"1398_CR110","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.120.316982","volume":"126","author":"J Backs","year":"2020","unstructured":"Backs J. CaMKII Transforms Glucose Into Reactive Oxygen Species. Circul Res. 2020;126:1327\u20139. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316982.","journal-title":"Circul Res"},{"key":"1398_CR111","doi-asserted-by":"publisher","unstructured":"Cucu I, Nicolescu M, Busnatu S, Manole C. Dynamic involvement of telocytes in modulating multiple signaling pathways in cardiac cytoarchitecture. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23105769.","DOI":"10.3390\/ijms23105769"},{"key":"1398_CR112","doi-asserted-by":"publisher","unstructured":"Sala-Gaston J, Pedrazza L, Ramirez J, Martinez-Martinez A, Rawlins L, Baple E, Crosby A, Mayor U, Ventura F, Rosa J. HERC2 deficiency activates C-RAF\/MKK3\/p38 signalling pathway altering the cellular response to oxidative stress. Cell Mol Life Sci. 2022;79. https:\/\/doi.org\/10.1007\/s00018-022-04586-7.","DOI":"10.1007\/s00018-022-04586-7"},{"key":"1398_CR113","doi-asserted-by":"crossref","unstructured":"Urbanek K, Donniacuo M, Cappetta D, Telesca M, Riemma M, Bellocchio G, Berrino L, Rossi F, Castaldo G, De Angelis A. Initial phase of anthracycline cardiotoxicity involves metabolic switch and activation of cardiac fibroblasts. Eur Heart J. 2023;44.","DOI":"10.1093\/eurheartj\/ehad655.777"},{"key":"1398_CR114","doi-asserted-by":"publisher","unstructured":"Packard RRS. Cardiac fibrosis in oncologic therapies. Curr Opin Physiol. 2022;29. https:\/\/doi.org\/10.1016\/j.cophys.2022.100575.","DOI":"10.1016\/j.cophys.2022.100575"},{"key":"1398_CR115","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/cells14181471","volume":"14","author":"F Meshrkey","year":"2025","unstructured":"Meshrkey F, Ibrahim SY, Bagchi RA, Richardson WJ. Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity. Cells. 2025;14:1471.","journal-title":"Cells"},{"key":"1398_CR116","first-page":"23","volume":"4","author":"K Yasmin","year":"2024","unstructured":"Yasmin K, Vivienne A, Valentina G, Gabriela Z. The role of senescence in cancer therapy-associated cardiovascular toxicity. J Cardiovasc Aging. 2024;4:23.","journal-title":"J Cardiovasc Aging"},{"key":"1398_CR117","doi-asserted-by":"crossref","unstructured":"Appels Y, Yousif LIE, Pieters CS, de Boer RA, Aboumsallem JP, Meijers WC. Cardiotoxicity beyond cardiomyocytes-focus on the role of cardiac fibroblasts and endothelial cells. Heart Lung Circ. 2025.","DOI":"10.1016\/j.hlc.2024.11.010"},{"key":"1398_CR118","doi-asserted-by":"publisher","unstructured":"Patricelli C, Lehmann P, Oxford J, Pu X. Doxorubicin-induced modulation of TGF-\u03b2 signaling cascade in mouse fibroblasts: insights into cardiotoxicity mechanisms. Sci Rep. 2023;13. https:\/\/doi.org\/10.1038\/s41598-023-46216-7.","DOI":"10.1038\/s41598-023-46216-7"},{"key":"1398_CR119","doi-asserted-by":"publisher","unstructured":"Terwoord J, Beyer A, Gutterman D. Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther. 2022;237. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108116.","DOI":"10.1016\/j.pharmthera.2022.108116"},{"key":"1398_CR120","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.mayocp.2025.08.019","volume":"101","author":"Z Zalaquett","year":"2026","unstructured":"Zalaquett Z, Shukla N, Hajj J, El Helou M, Moudgil R, Collier P. Cardiovascular Toxicity of Fluoropyrimidines: What We Know. Mayo Clin Proc. 2026;101:136\u201355. https:\/\/doi.org\/10.1016\/j.mayocp.2025.08.019.","journal-title":"Mayo Clin Proc"},{"key":"1398_CR121","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/atvbaha.124.319864","volume":"44","author":"R Travers","year":"2024","unstructured":"Travers R, Stepanian A, Jaffe I. Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors. Arterioscler Thromb Vascular Biology. 2024;44:2143\u201353. https:\/\/doi.org\/10.1161\/atvbaha.124.319864.","journal-title":"Arterioscler Thromb Vascular Biology"},{"key":"1398_CR122","doi-asserted-by":"publisher","unstructured":"Feng S, Zhao B, Sha S, Bu X, Zhang Z, Liu G, Chen H. Overview of immune checkpoint inhibitor associated myocarditis mechanisms diagnostics and treatment. Front Immunol. 2025;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1677984.","DOI":"10.3389\/fimmu.2025.1677984"},{"key":"1398_CR123","doi-asserted-by":"publisher","unstructured":"Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, Chen S, Xu X, Huang S, Liu C. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Therapy. 2024;9. https:\/\/doi.org\/10.1038\/s41392-024-01840-1.","DOI":"10.1038\/s41392-024-01840-1"},{"key":"1398_CR124","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/jcdd11020045","volume":"11","author":"A Kosobucka-Ozdoba","year":"2024","unstructured":"Kosobucka-Ozdoba A, Pietrzykowski \u0141, Michalski P, Ratajczak J, Grzelakowska K, Kasprzak M, Kubica J, Kubica A. Achieving Cardiovascular Risk Management Goals and Patient Quality of Life. J Cardiovasc Dev Disease. 2024;11:45.","journal-title":"J Cardiovasc Dev Disease"},{"key":"1398_CR125","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s11886-024-02131-5","volume":"26","author":"E Hutchins","year":"2024","unstructured":"Hutchins E, Yang EH, Stein-Merlob AF. Inflammation in Chemotherapy-Induced Cardiotoxicity. Curr Cardiol Rep. 2024;26:1329\u201340. https:\/\/doi.org\/10.1007\/s11886-024-02131-5.","journal-title":"Curr Cardiol Rep"},{"key":"1398_CR126","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11886-023-01906-6","volume":"25","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Jia H, Hua X, An T, Song J. Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism. Curr Cardiol Rep. 2023;25:863\u201378. https:\/\/doi.org\/10.1007\/s11886-023-01906-6.","journal-title":"Curr Cardiol Rep"},{"key":"1398_CR127","doi-asserted-by":"publisher","first-page":"117745","DOI":"10.1016\/j.bcp.2026.117745","volume":"247","author":"J Wei","year":"2026","unstructured":"Wei J, Zhao Q, Lu C, Gao C, Mu Z, Dong D, Sun M. Cellular crosstalk in doxorubicin-induced cardiotoxicity: underlying mechanisms and therapeutic strategies. Biochem Pharmacol. 2026;247:117745. https:\/\/doi.org\/10.1016\/j.bcp.2026.117745.","journal-title":"Biochem Pharmacol"},{"key":"1398_CR128","doi-asserted-by":"publisher","unstructured":"Koukorava C, Ahmed K, Almaghrabi S, Pointon A, Haddrick M, Cross M. Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells. Front Cardiovasc Med. 2024;11. https:\/\/doi.org\/10.3389\/fcvm.2024.1372817.","DOI":"10.3389\/fcvm.2024.1372817"},{"key":"1398_CR129","doi-asserted-by":"publisher","unstructured":"Kong Y, He R, He H, Liao L, Wu C, Chen X, Peng X. Precision monitoring strategies for chemotherapy-induced cardiotoxicity: a review of molecular indicators for early detection and risk stratification. Rev Cardiovasc Med. 2026;27. https:\/\/doi.org\/10.31083\/rcm45852.","DOI":"10.31083\/rcm45852"},{"key":"1398_CR130","doi-asserted-by":"publisher","unstructured":"Szponar J, Ciechanski E, Ciechanska M, Dudka J, Mandziuk S. Evolution of theories on doxorubicin-induced late cardiotoxicity-role of topoisomerase. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms252413567.","DOI":"10.3390\/ijms252413567"},{"key":"1398_CR131","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","volume":"9","author":"L Wu","year":"2024","unstructured":"Wu L, Zhang Y, Wang G, Ren JM. Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity. Jacc-Basic Translational Sci. 2024;9:811\u201326. https:\/\/doi.org\/10.1016\/j.jacbts.2023.10.009.","journal-title":"Jacc-Basic Translational Sci"},{"key":"1398_CR132","doi-asserted-by":"publisher","unstructured":"Zhao J, Zhang N, Ma X, Li M, Feng H. The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity. Cell Death Discovery. 2023;9. https:\/\/doi.org\/10.1038\/s41420-023-01483-1.","DOI":"10.1038\/s41420-023-01483-1"},{"key":"1398_CR133","doi-asserted-by":"publisher","unstructured":"Dufour C, Xia H, B\u2019chir W, Perry M, Kuzmanov U, Gainullina A, Dejgaard K, Scholtes C, Ouellet C, Zuo D, et al. Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERR\u03b1 deficiency. Commun Biology. 2022;5. https:\/\/doi.org\/10.1038\/s42003-022-03942-4.","DOI":"10.1038\/s42003-022-03942-4"},{"key":"1398_CR134","doi-asserted-by":"publisher","unstructured":"Lin M, Xiong W, Wang S, Li Y, Hou C, Li C, Li G. The research progress of trastuzumab-induced cardiotoxicity in HER-2-positive breast cancer treatment. Front Cardiovasc Med. 2022;8. https:\/\/doi.org\/10.3389\/fcvm.2021.821663.","DOI":"10.3389\/fcvm.2021.821663"},{"key":"1398_CR135","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2023.06.019","volume":"206","author":"T Ye","year":"2023","unstructured":"Ye T, Yang W, Gao T, Yu X, Chen T, Yang Y, Guo J, Li Q, Li H, Yang L. Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction. Free Radic Biol Med. 2023;206:143\u201361. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.019.","journal-title":"Free Radic Biol Med"},{"key":"1398_CR136","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/15548627.2023.2259216","volume":"20","author":"Z Xu","year":"2024","unstructured":"Xu Z, Pan Z, Jin Y, Gao Z, Jiang F, Fu H, Chen X, Zhang X, Yan H, Yang X, et al. Inhibition of PRKAA\/AMPK (Ser485\/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusion. Autophagy. 2024;20:416\u201336. https:\/\/doi.org\/10.1080\/15548627.2023.2259216.","journal-title":"Autophagy"},{"key":"1398_CR137","doi-asserted-by":"publisher","unstructured":"Shyam Sunder S, Sharma UC, Pokharel S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct Target Therapy. 2023;8. https:\/\/doi.org\/10.1038\/s41392-023-01469-6.","DOI":"10.1038\/s41392-023-01469-6"},{"key":"1398_CR138","doi-asserted-by":"publisher","unstructured":"Feng S, Zhao B, Sha S, Bu X, Zhang Z, Liu G, Chen H. Overview of immune checkpoint inhibitor associated myocarditis mechanisms diagnostics and treatment. Front Immunol. 2025;16\u20132025. https:\/\/doi.org\/10.3389\/fimmu.2025.1677984.","DOI":"10.3389\/fimmu.2025.1677984"},{"key":"1398_CR139","doi-asserted-by":"publisher","unstructured":"Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, Jiang X, Wu F, He G. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023;14. https:\/\/doi.org\/10.1038\/s41419-023-06370-2.","DOI":"10.1038\/s41419-023-06370-2"},{"key":"1398_CR140","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1007\/s10753-025-02298-1","volume":"48","author":"J Sun","year":"2025","unstructured":"Sun J, Wu W, Wang Y, Zhang J, Qiu S, Guan Z, Shi C, Ma J, Xu Y. MLKL\u2013Mediated Necroptosis Predominantly Contributes to Immune-Associated Myocardial Damage. Inflammation. 2025;48:3878\u201397. https:\/\/doi.org\/10.1007\/s10753-025-02298-1.","journal-title":"Inflammation"},{"key":"1398_CR141","doi-asserted-by":"publisher","unstructured":"Abdelgawad I, Agostinucci K, Zordoky B. Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors. Biochim Et Biophys Acta-Molecular Basis Disease. 2022;1868. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166352.","DOI":"10.1016\/j.bbadis.2022.166352"},{"key":"1398_CR142","doi-asserted-by":"publisher","unstructured":"Nguyen T, Bordeau B, Balthasar J. Mechanisms of ADC toxicity and strategies to increase ADC tolerability. Cancers. 2023;15. https:\/\/doi.org\/10.3390\/cancers15030713.","DOI":"10.3390\/cancers15030713"},{"key":"1398_CR143","doi-asserted-by":"publisher","unstructured":"Long P, Li S, Pan L, Wang Y, Chen W, Wang X. Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1378010.","DOI":"10.3389\/fphar.2024.1378010"},{"key":"1398_CR144","doi-asserted-by":"publisher","unstructured":"Alshoubaki YK, Gr\u00fcterich V, Zollet V, Kuster GM. The role of senescence in cancer therapy-associated cardiovascular toxicity. J Cardiovasc Aging. 2024;4. https:\/\/doi.org\/10.20517\/jca.2024.14.","DOI":"10.20517\/jca.2024.14"},{"key":"1398_CR145","doi-asserted-by":"publisher","unstructured":"Wei J, Zhao Q, Lu C, Gao C, Mu Z, Dong D, Sun M. Cellular crosstalk in doxorubicin-induced cardiotoxicity: underlying mechanisms and therapeutic strategies. Biochem Pharmacol. 2026;247. https:\/\/doi.org\/10.1016\/j.bcp.2026.117745.","DOI":"10.1016\/j.bcp.2026.117745"},{"key":"1398_CR146","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10741-025-10531-0","volume":"30","author":"S Shil","year":"2025","unstructured":"Shil S, Kumar P, Mumbrekar KD. Cancer therapy-induced cardiotoxicity: mechanisms and mitigations. Heart Fail Rev. 2025;30:1075\u201392. https:\/\/doi.org\/10.1007\/s10741-025-10531-0.","journal-title":"Heart Fail Rev"},{"key":"1398_CR147","doi-asserted-by":"crossref","unstructured":"Alshoubaki YK, Gr\u00fcterich V, Zollet V, Kuster GM. The role of senescence in cancer therapy-associated cardiovascular toxicity. J Cardiovasc Aging 2024.","DOI":"10.20517\/jca.2024.14"},{"key":"1398_CR148","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/cvr\/cvac087","volume":"119","author":"C Tonry","year":"2023","unstructured":"Tonry C, Russell-Hallinan A, McCune C, Collier P, Harbinson M, Dixon L, Watson CJ. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction. Cardiovascular Res. 2023;119:710\u201328. https:\/\/doi.org\/10.1093\/cvr\/cvac087.","journal-title":"Cardiovascular Res"},{"key":"1398_CR149","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/biom14020199","volume":"14","author":"U Attanasio","year":"2024","unstructured":"Attanasio U, Di Sarro E, Tricarico L, Di Lisi D, Armentaro G, Miceli S, Fioretti F, Deidda M, Correale M, Novo G, et al. Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond. Biomolecules. 2024;14:199.","journal-title":"Biomolecules"},{"key":"1398_CR150","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11864-024-01203-6","volume":"25","author":"Z Kuang","year":"2024","unstructured":"Kuang Z, Kong M, Yan N, Ma X, Wu M, Li J. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods. Curr Treat Options Oncol. 2024;25:679\u2013701. https:\/\/doi.org\/10.1007\/s11864-024-01203-6.","journal-title":"Curr Treat Options Oncol"},{"key":"1398_CR151","doi-asserted-by":"publisher","unstructured":"Mao H, Hu J, Yu C, Xie S, Chang C, Peng J, Zhang Y. MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances. Front Cardiovasc Med. 2025;12\u20132025. https:\/\/doi.org\/10.3389\/fcvm.2025.1614878.","DOI":"10.3389\/fcvm.2025.1614878"},{"key":"1398_CR152","doi-asserted-by":"publisher","unstructured":"Brown C, Mantzaris M, Nicolaou E, Karanasiou G, Papageorgiou E, Curigliano G, Cardinale D, Filippatos G, Memos N, Naka KK, et al. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research. Cardiooncology. 2022;8. https:\/\/doi.org\/10.1186\/s40959-022-00142-1.","DOI":"10.1186\/s40959-022-00142-1"},{"key":"1398_CR153","doi-asserted-by":"publisher","unstructured":"Han D, Wang T, Li X, Qin C, Zhang Y, Zhou T, Gao S, Zhang W, Wang Y, Ma Y, et al. Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox Biol. 2025;86. https:\/\/doi.org\/10.1016\/j.redox.2025.103843.","DOI":"10.1016\/j.redox.2025.103843"},{"key":"1398_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07828-5","author":"R Sanwlani","year":"2025","unstructured":"Sanwlani R, Camelliti P. Extracellular Vesicles in Cardiac Cell Crosstalk: from Intercellular Communication to Clinical Translation. Cardiovasc Drugs Ther. 2025https:\/\/doi.org\/10.1007\/s10557-025-07828-5.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1398_CR155","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","volume":"9","author":"L Wu","year":"2024","unstructured":"Wu L, Zhang Y, Wang G, Ren JM. Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity. JACC: Basic Translational Sci. 2024;9:811\u201326. https:\/\/doi.org\/10.1016\/j.jacbts.2023.10.009.","journal-title":"JACC: Basic Translational Sci"},{"key":"1398_CR156","doi-asserted-by":"publisher","unstructured":"Sun S-J, Jiao X-D, Chen Z-G, Cao Q, Zhu J-H, Shen Q-R, Liu Y, Zhang Z, Xu F-F, Shi Y, et al. Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-50996-5.","DOI":"10.1038\/s41467-024-50996-5"},{"key":"1398_CR157","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","volume":"97","author":"SM Swain","year":"2003","unstructured":"Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97:2869\u201379. https:\/\/doi.org\/10.1002\/cncr.11407.","journal-title":"Cancer"},{"key":"1398_CR158","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci. 2019;116:2672\u201380. https:\/\/doi.org\/10.1073\/pnas.1821022116.","journal-title":"Proc Natl Acad Sci"},{"key":"1398_CR159","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/circulationaha.115.018347","volume":"133","author":"J Herrmann","year":"2016","unstructured":"Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New\u2013An Evolving Avenue. Circulation. 2016;133:1272\u201389. https:\/\/doi.org\/10.1161\/circulationaha.115.018347.","journal-title":"Circulation"},{"key":"1398_CR160","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019;116:2672\u201380. https:\/\/doi.org\/10.1073\/pnas.1821022116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1398_CR161","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.25122\/jml-2023-0098","volume":"16","author":"N Al-Hammadi","year":"2023","unstructured":"Al-Hammadi N, AlSabri E, Kudhair AH, Qassam H, Hadi NR. Coq10 for preventing cardiotoxicity in breast cancer patients treated with trastuzumab. J Med Life. 2023;16:1188\u201393. https:\/\/doi.org\/10.25122\/jml-2023-0098.","journal-title":"J Med Life"},{"key":"1398_CR162","doi-asserted-by":"publisher","first-page":"244","DOI":"10.31083\/j.fbl2708244","volume":"27","author":"Z Pei","year":"2022","unstructured":"Pei Z, Ma L, Li Y, Yang J, Yang Q, Yao W, Li S. CoQ10 Improves Myocardial Damage in Doxorubicin-Induced Heart Failure in C57BL\/6 Mice. Front Biosci (Landmark Ed). 2022;27:244. https:\/\/doi.org\/10.31083\/j.fbl2708244.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1398_CR163","doi-asserted-by":"publisher","unstructured":"Zhang G, Yuan C, Su X, Zhang J, Gokulnath P, Vulugundam G, Li G, Yang X, An N, Liu C et al. Relevance of ferroptosis to cardiotoxicity caused by anthracyclines: mechanisms to target treatments. Front Cardiovasc Med 2022;9\u20132022. https:\/\/doi.org\/10.3389\/fcvm.2022.896792","DOI":"10.3389\/fcvm.2022.896792"},{"key":"1398_CR164","doi-asserted-by":"publisher","unstructured":"Maldonado-Salinas R, Caballero-Salazar S, Castillejos-L\u00f3pez M, Aquino-G\u00e1lvez A, Velasco-Hidalgo L, Garc\u00eda-Guzm\u00e1n A, Pliego-Villanueva C, Alavez-P\u00e9rez NS, Montesinos-Correa H, Torres-Esp\u00edndola LM. Omega-3 fatty acids and chemotherapy-induced toxicities: mechanisms and emerging evidence with a pediatric focus. Nutr Metab (Lond). 2025;22. https:\/\/doi.org\/10.1186\/s12986-025-01044-6.","DOI":"10.1186\/s12986-025-01044-6"},{"key":"1398_CR165","doi-asserted-by":"publisher","unstructured":"Chen M, Fu B, Zhou H, Wu Q. Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review. Front Pharmacol. 2025;16\u20132025. https:\/\/doi.org\/10.3389\/fphar.2025.1528208.","DOI":"10.3389\/fphar.2025.1528208"},{"key":"1398_CR166","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ehjcvp\/pvac051","volume":"9","author":"T L\u00f3pez-Fern\u00e1ndez","year":"2022","unstructured":"L\u00f3pez-Fern\u00e1ndez T, Lyon AR, Herrmann J. ESC Guidelines on cardio-oncology: how can we improve the cardiovascular health of patients with cancer and cancer survivors? Eur Heart J Cardiovasc Pharmacother. 2022;9:4\u20135. . https:\/\/doi.org\/10.1093\/ehjcvp\/pvac051","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"1398_CR167","doi-asserted-by":"publisher","first-page":"e029574","DOI":"10.1161\/jaha.123.029574","volume":"12","author":"G Murtagh","year":"2023","unstructured":"Murtagh G, Januzzi JL, Scherrer-Crosbie M, Neilan TG, Dent S, Ho JE, Appadurai V, McDermott R, Akhter N. Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions. J Am Heart Assoc. 2023;12:e029574. https:\/\/doi.org\/10.1161\/jaha.123.029574.","journal-title":"J Am Heart Assoc"},{"key":"1398_CR168","doi-asserted-by":"crossref","unstructured":"Li J, Chen H, Xu C, Hu M, Li J, Chang W. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention. Front Immunol 2024;15.","DOI":"10.3389\/fimmu.2024.1422591"},{"key":"1398_CR169","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cpt.2024.04.004","volume":"3","author":"B Rachma","year":"2025","unstructured":"Rachma B, Savitri M, Sutanto H. Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management. Cancer Pathog Ther. 2025;3:101\u20138. https:\/\/doi.org\/10.1016\/j.cpt.2024.04.004.","journal-title":"Cancer Pathog Ther"},{"key":"1398_CR170","doi-asserted-by":"publisher","first-page":"e010127","DOI":"10.1136\/jitc-2024-010127","volume":"13","author":"Y Lu","year":"2025","unstructured":"Lu Y, Gao J, Hou Y, Yang H, Wang D, Zhang G, Qin Z, Du P, Wang Z, Wang Y, et al. Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers. J Immunother Cancer. 2025;13:e010127. https:\/\/doi.org\/10.1136\/jitc-2024-010127.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"1398_CR171","doi-asserted-by":"publisher","first-page":"e70010","DOI":"10.1002\/mco2.70010","volume":"2024","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Meng Y, Le J, Sun Y, Dian Y, Yao L, Xiong Y, Zeng F, Chen X, Deng G. Ferroptosis: mechanisms and therapeutic targets. MedComm. 2020;2024(5):e70010. https:\/\/doi.org\/10.1002\/mco2.70010.","journal-title":"MedComm"},{"key":"1398_CR172","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41420-023-01483-1","volume":"9","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhang N, Ma X, Li M, Feng H. The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity. Cell Death Discov. 2023;9:184. https:\/\/doi.org\/10.1038\/s41420-023-01483-1.","journal-title":"Cell Death Discov"},{"key":"1398_CR173","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.pharmthera.2022.108116","volume":"237","author":"JD Terwoord","year":"2022","unstructured":"Terwoord JD, Beyer AM, Gutterman DD. Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther. 2022;237:108116. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108116.","journal-title":"Pharmacol Ther"},{"key":"1398_CR174","doi-asserted-by":"publisher","first-page":"107195","DOI":"10.1016\/j.vph.2023.107195","volume":"152","author":"M Anastasiou","year":"2023","unstructured":"Anastasiou M, Oikonomou E, Theofilis P, Papamikroulis GA, Gazouli M, Kalogeras K, Lygkoni S, Pesiridis T, Goliopoulou A, Papatheodoridi A, et al. Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients. Vascul Pharmacol. 2023;152:107195. https:\/\/doi.org\/10.1016\/j.vph.2023.107195.","journal-title":"Vascul Pharmacol"},{"key":"1398_CR175","doi-asserted-by":"publisher","unstructured":"Dufour CR, Xia H, B\u2019chir W, Perry M-C, Kuzmanov U, Gainullina A, Dejgaard K, Scholtes C, Ouellet C, Zuo D, et al. Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERR\u03b1 deficiency. Commun Biology. 2022;5. https:\/\/doi.org\/10.1038\/s42003-022-03942-4.","DOI":"10.1038\/s42003-022-03942-4"},{"key":"1398_CR176","doi-asserted-by":"crossref","unstructured":"Lin M-b, Xiong W, Wang S, Li Y, Hou C, Li C, Li G. The research progress of trastuzumab-induced cardiotoxicity in HER-2-positive breast cancer treatment. Front Cardiovasc Med 2022;8.","DOI":"10.3389\/fcvm.2021.821663"},{"key":"1398_CR177","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.1113\/jp272885","volume":"594","author":"T Yu","year":"2016","unstructured":"Yu T, Deuster P, Chen Y. Role of dynamin-related protein 1-mediated mitochondrial fission in resistance of mouse C2C12 myoblasts to heat injury. J Physiol. 2016;594:7419\u201333. https:\/\/doi.org\/10.1113\/jp272885.","journal-title":"J Physiol"},{"key":"1398_CR178","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/cvr\/cvaf095","volume":"121","author":"S Zhuang","year":"2025","unstructured":"Zhuang S, Wang B, Wu E, Lin J, Zeng W, Liu M, Yang J, Zhang X. Adverse cardiac events associated with antibody-drug conjugates in cancer patients: retrospective analysis of FAERS database and RCTs. Cardiovascular Res. 2025;121:2318\u201333. https:\/\/doi.org\/10.1093\/cvr\/cvaf095.","journal-title":"Cardiovascular Res"},{"key":"1398_CR179","doi-asserted-by":"publisher","unstructured":"Abdelgawad IY, Agostinucci K, Zordoky BN. Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors. Biochim Biophys Acta Mol Basis Dis. 2022;1868. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166352.","DOI":"10.1016\/j.bbadis.2022.166352"},{"key":"1398_CR180","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/ejhf.2346","volume":"23","author":"WC Meijers","year":"2021","unstructured":"Meijers WC, Bayes-Genis A, Mebazaa A, Bauersachs J, Cleland JGF, Coats AJS, Januzzi JL, Maisel AS, McDonald K, Mueller T, et al. Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC). Eur J Heart Fail. 2021;23:1610\u201332. https:\/\/doi.org\/10.1002\/ejhf.2346.","journal-title":"Eur J Heart Fail"},{"key":"1398_CR181","doi-asserted-by":"publisher","first-page":"106616","DOI":"10.1016\/j.biocel.2024.106616","volume":"173","author":"D Das","year":"2024","unstructured":"Das D, Jothimani G, Banerjee A, Dey A, Duttaroy AK, Pathak S. A brief review on recent advances in diagnostic and therapeutic applications of extracellular vesicles in cardiovascular disease. Int J Biochem Cell Biol. 2024;173:106616. https:\/\/doi.org\/10.1016\/j.biocel.2024.106616.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1398_CR182","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1002\/mco2.454","volume":"2023","author":"Q Li","year":"2020","unstructured":"Li Q, Feng Q, Zhou H, Lin C, Sun X, Ma C, Sun L, Guo G, Wang D. Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases. MedComm. 2020;2023(4):e454. https:\/\/doi.org\/10.1002\/mco2.454.","journal-title":"MedComm"},{"key":"1398_CR183","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z. GPX4, ferroptosis, and diseases. Biomed Pharmacother. 2024;174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512.","journal-title":"Biomed Pharmacother"},{"key":"1398_CR184","doi-asserted-by":"publisher","unstructured":"Dogan Z, Senyigit A, Dumur S, Fevziye Misirlioglu N, Uzun N, Aydin SN, Melekoglu A, Altinbilek E, \u00c7akatay U, Uzun H. Circulating biomarkers associated with pyroptosis in the differential diagnosis of ST-segment elevation and non-ST-segment elevation myocardial infarction. Front Cardiovasc Med. 2025;12. https:\/\/doi.org\/10.3389\/fcvm.2025.1648568.","DOI":"10.3389\/fcvm.2025.1648568"},{"key":"1398_CR185","doi-asserted-by":"publisher","first-page":"e033675","DOI":"10.1161\/jaha.123.033675","volume":"13","author":"O Salman","year":"2024","unstructured":"Salman O, Zamani P, Zhao L, Dib MJ, Gan S, Azzo JD, Pourmussa B, Richards AM, Javaheri A, Mann DL, et al. Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure. J Am Heart Assoc. 2024;13:e033675. https:\/\/doi.org\/10.1161\/jaha.123.033675.","journal-title":"J Am Heart Assoc"},{"key":"1398_CR186","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","volume":"44","author":"L Yang","year":"2023","unstructured":"Yang L, Yang P, Lip GYH, Ren J. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci. 2023;44:573\u201385. https:\/\/doi.org\/10.1016\/j.tips.2023.07.004.","journal-title":"Trends Pharmacol Sci"},{"key":"1398_CR187","first-page":"CD014638","volume":"9","author":"EC de Baat","year":"2022","unstructured":"de Baat EC, Mulder RL, Armenian S, Feijen EA, Grotenhuis H, Hudson MM, Mavinkurve-Groothuis AM, Kremer LC, van Dalen EC. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines. Cochrane Database Syst Rev. 2022;9:CD014638.","journal-title":"Cochrane Database Syst Rev"},{"key":"1398_CR188","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jaccao.2024.02.004","volume":"6","author":"JN Upshaw","year":"2024","unstructured":"Upshaw JN, Parson SK, Buchsbaum RJ, Schlam I, Ruddy KJ, Durani U, Epperla N, Leong DP. Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines: JACC: CardioOncology Controversies in Cardio-Oncology. JACC CardioOncol. 2024;6:322\u20134.","journal-title":"JACC CardioOncol"},{"key":"1398_CR189","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022;43:4229\u2013361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244.","journal-title":"Eur Heart J"},{"key":"1398_CR190","doi-asserted-by":"publisher","unstructured":"Jiang R, Lou L, Shi W, Chen Y, Fu Z, Liu S, Sok T, Li Z, Zhang X, Yang J. Statins in mitigating anticancer treatment-related cardiovascular disease. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms251810177.","DOI":"10.3390\/ijms251810177"},{"key":"1398_CR191","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/circresaha.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res. 2017;120:229\u201343. https:\/\/doi.org\/10.1161\/circresaha.116.308537.","journal-title":"Circ Res"},{"key":"1398_CR192","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/apjon.apjon_3_19","volume":"6","author":"S Trinh","year":"2019","unstructured":"Trinh S, Le A, Gowani S, La-Beck NM. Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines. Asia Pac J Oncol Nurs. 2019;6:154\u201360. https:\/\/doi.org\/10.4103\/apjon.apjon_3_19.","journal-title":"Asia Pac J Oncol Nurs"},{"key":"1398_CR193","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","volume":"24","author":"JM Busillo","year":"2013","unstructured":"Busillo JM, Cidlowski JA. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab. 2013;24:109\u201319. https:\/\/doi.org\/10.1016\/j.tem.2012.11.005.","journal-title":"Trends Endocrinol Metab"},{"key":"1398_CR194","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/JCO.21.01992","volume":"39","author":"BD Santomasso","year":"2021","unstructured":"Santomasso BD, Nastoupil LJ, Adkins S, Lacchetti C, Schneider BJ, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, et al. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. J Clin Oncol. 2021;39:3978\u201392. https:\/\/doi.org\/10.1200\/JCO.21.01992.","journal-title":"J Clin Oncol"},{"key":"1398_CR195","doi-asserted-by":"publisher","unstructured":"Greenlee H, Crew KD, Maurer M, Kalinsky K, Cremers S, Naini A, Tsai WY, Shi Z, Brogan F, Hershman DL, Phase I, Randomized. placebo-controlled, cross-over dose-finding study of coenzyme Q10 on doxorubicin pharmacokinetics during breast cancer treatment. Integr Cancer Ther. 2025;24. https:\/\/doi.org\/10.1177\/15347354251388014.","DOI":"10.1177\/15347354251388014"},{"key":"1398_CR196","doi-asserted-by":"publisher","first-page":"e042534","DOI":"10.1161\/jaha.125.042534","volume":"14","author":"H Nsairat","year":"2025","unstructured":"Nsairat H, Lafi Z, Abualsoud BM, Al-Najjar BO, Al-Samydai A, Oriquat GA, Alshaer W, Alqader Ibrahim A, Dellinger AL. Vitamin C as a Cardioprotective Agent Against Doxorubicin-Induced Cardiotoxicity. J Am Heart Assoc. 2025;14:e042534. https:\/\/doi.org\/10.1161\/jaha.125.042534.","journal-title":"J Am Heart Assoc"},{"key":"1398_CR197","doi-asserted-by":"crossref","unstructured":"Huang J, Wu R-h, Chen L, Yang Z, Yan D, Li M. Understanding anthracycline cardiotoxicity from mitochondrial aspect. Fronti Pharmacol 2022;13.","DOI":"10.3389\/fphar.2022.811406"},{"key":"1398_CR198","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/eurheartj\/ehw247","volume":"38","author":"I Hoefer","year":"2017","unstructured":"Hoefer I, Pasterkamp G, Robertson A, de Jager S, Arslan F, Cooper M, van Solinge W, de Haan J, Ellenbroek G, Bosch L, et al. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction. Eur Heart J. 2017;38:828\u201336. https:\/\/doi.org\/10.1093\/eurheartj\/ehw247.","journal-title":"Eur Heart J"},{"issue":"2680","key":"1398_CR199","doi-asserted-by":"publisher","first-page":"TPS2680","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS2680","volume":"41","author":"KL Reynolds","year":"2023","unstructured":"Reynolds KL, Zlotoff DA, Mooradian M, Zubiri L, Ridker P, Neilan TG. Abatacept for immune checkpoint inhibitor associated myocarditis (ATRIUM): Phase 3, investigator-initiated, randomized, placebo-controlled study to evaluate the efficacy and safety of abatacept compared to placebo in hospitalized patients with immune checkpoint inhibitor associated myocarditis. J Clin Oncol. 2023;41(2680):TPS2680\u2013TPS. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.TPS2680.","journal-title":"J Clin Oncol"},{"key":"1398_CR200","doi-asserted-by":"publisher","first-page":"112007","DOI":"10.1016\/j.mad.2024.112007","volume":"223","author":"M Scalise","year":"2025","unstructured":"Scalise M, Cianflone E, Quercia C, Pagano L, Chiefalo A, Stincelli A, Torella A, Puccio B, Santamaria G, Guzzi HP, et al. Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids. Mech Ageing Dev. 2025;223:112007. https:\/\/doi.org\/10.1016\/j.mad.2024.112007.","journal-title":"Mech Ageing Dev"},{"key":"1398_CR201","doi-asserted-by":"publisher","first-page":"113078","DOI":"10.1016\/j.intimp.2024.113078","volume":"142","author":"Y Hu","year":"2024","unstructured":"Hu Y, Yu J, He W, Qiao Y, Cheng X, Huang H, Lai S, Yin D, He H. Astragaloside IV intervenes multi-regulatory cell death forms against doxorubicin-induced cardiotoxicity by regulating AMPK\u03b12 pathway. Int Immunopharmacol. 2024;142:113078. https:\/\/doi.org\/10.1016\/j.intimp.2024.113078.","journal-title":"Int Immunopharmacol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-026-01398-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:16:14Z","timestamp":1782846974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-026-01398-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":201,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1007\/s11864-026-01398-w","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"34"}}